Navigation Links
GRU joins national research cooperative to improve reproductive health
Date:12/31/2013

Augusta, Ga. - Georgia Regents University has joined the national Cooperative Multicenter Reproductive Medicine Network designed to enable large clinical trials that improve the diagnosis and treatment of reproductive health issues such as male and female infertility.

"These types of trials answer important questions about the care of infertile couples and they allow us to offer services to the community that would not otherwise be available," said Dr. Michael P. Diamond, a reproductive endocrinologist and Chairman of the Department of Obstetrics and Gynecology at the Medical College of Georgia at GRU.

Network participation also complements human studies at MCG to better understand complex reproductive issues such as delayed puberty and polycystic ovary syndrome, Diamond said. One of the first network studies he hopes to bring to MCG is evaluating the impact of multiple births on parents, siblings, and extended family, and how they adapt.

Diamond has served for more than a decade as a Principal Investigator of the network of the National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development.

When he came to MCG in early 2013 from Wayne State University in Detroit, he aimed to make MCG and the university part of that network, which also includes the University of North Carolina, Pennsylvania State University, the University of Pennsylvania, the University of California, San Francisco, and the University of Oklahoma.

"The large number of patients and investigators involved with this network enable novel diagnostic and treatment strategies for complex reproductive system issues to move forward with the greatest possible safety and efficiency," Diamond said. "We are excited to be part of this national initiative."

For example, network findings recently presented at the International Federation of Fertility Societies/American Society of Reproductive Medicine Annual Meeting indicate that an aromatase inhibitor used to treat breast cancer is also effective as inducing ovulation that results in the birth of healthy babies to women with polycystic ovary syndrome. Letrozole, which is also less expensive than some other infertility therapies, produced higher birth rates without increasing rates of multiple births. Twins or triplets, which often occur as a result of fertility treatment, increase the risk of premature birth as well as prenatal complications.

The 20-year-old network has made the latest reproductive medicine therapies available to qualified patients at no cost. Diamond hopes future studies will enable that in Georgia as well, where much like Michigan, many diagnostic and treatment therapies are not covered by insurance. Additionally, extensive evaluations study participants receive may detect previously unknown conditions. For example, a recent polycystic ovary syndrome study identified cases of both breast and endometrial cancer, Diamond said.

Dr. Stephen A. Krawetz, Associate Director of the C.S. Mott Center for Human Growth and Development at Wayne State University, and Dr. Lawrence C. Layman, Chief of the MCG Section of Reproductive Endocrinology, Infertility, and Genetics, are Co-Investigators with Diamond.

MCG receives $1.75 million (grant number HD-39005) as part of the base funding for the network, which includes support for Diamond, Layman, and a research coordinator. Additional federal funds will come to MCG for participation in individual clinical trials as part of the network.


'/>"/>

Contact: Toni Baker
tbaker@gru.edu
706-721-4421
Medical College of Georgia at Georgia Regents University
Source:Eurekalert  

Related medicine news :

1. Liz Deppe Joins Orangetheory Fitness
2. Feinstein Institute Researcher Joins International Partnership in Neuroscience Research
3. ProHEALTH Joins North Shore-LIJ CareConnect Provider Network
4. Leading North Shore Cosmetic Surgery Facility Joins Brilliant Distinctions Network
5. Roseann Duran Joins Camp Boggy Creek Board of Directors
6. MARS™ Director Participates in ONDCP Drug Policy Reform Conference at White House: Ginter Joins Panel on “Lifting the Stigma of Addiction” moderated by Patrick Kennedy
7. Mountainside Medical Equipment Joins the UPS Carbon Neutral Shipping Program
8. Career Step Physician Advisor Joins the ICD10monitor’s Editorial Board
9. First Women-Only Brazilian Jiu-Jitsu Classes Come to Columbus; AGC Champion, Heide Callentine, Joins Team Chitwood Instructor Staff
10. Florida-based Dr. Robert Dean Joins Relief Mission to Philippines
11. Deborah Walker Joins Cherry Bekaert as National Director of Compensation & Benefits Solutions
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
GRU joins national research cooperative to improve reproductive health
(Date:3/27/2017)... IL (PRWEB) , ... March 27, 2017 , ... ... systems, recently received the CE Certificate of Conformity for the Smart System® 20/20. ... or exceed the highest industry standards and specifications such as ANSI, ISO and ...
(Date:3/27/2017)... PA (PRWEB) , ... March 27, 2017 , ... ... business simulation -centric training, today announced the launch of a new research ... strategy, having the skills needed to execute that strategy, and the actual success ...
(Date:3/27/2017)... ... 2017 , ... According to the American Cancer Society , the average ... 95%. Once the cancer spreads to other organs, bones, or lymph nodes, however, the ... avoid this latter group, tune in to Lifestyle Magazine on April 9, ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... facility from 8:00am-10:00am on Monday, April 3rd to commemorate the two-year anniversary of ... opportunity for area-residents to celebrate two great years while also familiarizing themselves with ...
(Date:3/25/2017)... ... March 25, 2017 , ... Getting earned media coverage meaningful ... partner. , All through the year, Garden Media aims to provide material helpful ... key influencers and pitching client’s key messages to gain coveted media placements, ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... 2017 BioLineRx Ltd. (NASDAQ/TASE: BLRX), a ... that AGI-134, an immunotherapy for the treatment of multiple cancers, ... be featured at the upcoming American Association for Cancer ... to be held on April 1-5, 2017. ... An abstract ...
(Date:3/27/2017)... 2017 The global clinical ... billion by 2025, according to a new study by ... diseases is anticipated to be responsible for the high ... the scope for growth during the forecast period. In ... is highly susceptible to chronic diseases, is presumed to ...
(Date:3/27/2017)... March 27, 2017  Impax Laboratories, Inc. (NASDAQ: IPXL)today ... Paul M. Bisaro as Impax,s President and Chief ... effective March 27, 2017. Mr. Bisaro will succeed ... President and Chief Executive Officer since December of 2016. ... branded pharmaceutical experience, Mr. Bisaro, 56, is an accomplished ...
Breaking Medicine Technology: